Vor Biopharma (VOR)

• Market cap: $580M
• 1 day: 3.48%
• 5 days: -9.16%
• 1 month: 7.7%
• 3 months: -11.63%
• 6 months: -55.48%
• Year to date: 20.1%
• 1 year: -18.77%
• 5 years: -98.25%
• 10 years: -98.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Employees: 168